Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban Plus Aspirin vs Aspirin in CAD/PAD (China Cohort of COMPASS)
CTR20132869Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in coronary arteriosclerosis, arteriosclerosis obliterans, sponsored by Bayer. Started May 2014; status: completed.
02
Drugs
rivaroxaban
03
Conditions
coronary arteriosclerosisarteriosclerosis obliterans
Beyond the preview
Go deeper on CTR20132869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132869.